Global Infertility Testing Market Research Report 2024

Publication ID:

PB503244898

Publication Date:

March 15, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Fertility testing is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are performed based on the completion of this three step process. Men and women both experience the fertility problems at equal rates, but women are considered to be more concerned regarding fertility testing.
The global Infertility Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Decline in fertility rates, increasing number of fertility clinics, rising number of gynecological disorders and technological advancements and innovative testing products are expected to drive the growth of the market in the coming years. Increasing awareness among the female population is expected to offer growth opportunities for the manufacturers operating in the market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Infertility Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Testing.
Report Scope
The Infertility Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infertility Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infertility Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Procter & Gamble
BioMerieux
Abbott
Babystart
BioZhena Corporation
Quidel Corporation
SPD Swiss Precision Diagnostics GmbH
SCSA Diagnostics
Pride Angel
Segment by Type
Female Infertility Testing
Male Infertility Testing
Segment by Application
Hospitals
Clinics
Fertility Centers
Research Institutes
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infertility Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infertility Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Female Infertility Testing
1.2.3 Male Infertility Testing
1.3 Market by Application
1.3.1 Global Infertility Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Fertility Centers
1.3.5 Research Institutes
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infertility Testing Market Perspective (2019-2030)
2.2 Infertility Testing Growth Trends by Region
2.2.1 Global Infertility Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infertility Testing Historic Market Size by Region (2019-2024)
2.2.3 Infertility Testing Forecasted Market Size by Region (2025-2030)
2.3 Infertility Testing Market Dynamics
2.3.1 Infertility Testing Industry Trends
2.3.2 Infertility Testing Market Drivers
2.3.3 Infertility Testing Market Challenges
2.3.4 Infertility Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infertility Testing Players by Revenue
3.1.1 Global Top Infertility Testing Players by Revenue (2019-2024)
3.1.2 Global Infertility Testing Revenue Market Share by Players (2019-2024)
3.2 Global Infertility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infertility Testing Revenue
3.4 Global Infertility Testing Market Concentration Ratio
3.4.1 Global Infertility Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infertility Testing Revenue in 2023
3.5 Infertility Testing Key Players Head office and Area Served
3.6 Key Players Infertility Testing Product Solution and Service
3.7 Date of Enter into Infertility Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infertility Testing Breakdown Data by Type
4.1 Global Infertility Testing Historic Market Size by Type (2019-2024)
4.2 Global Infertility Testing Forecasted Market Size by Type (2025-2030)
5 Infertility Testing Breakdown Data by Application
5.1 Global Infertility Testing Historic Market Size by Application (2019-2024)
5.2 Global Infertility Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infertility Testing Market Size (2019-2030)
6.2 North America Infertility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infertility Testing Market Size by Country (2019-2024)
6.4 North America Infertility Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infertility Testing Market Size (2019-2030)
7.2 Europe Infertility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infertility Testing Market Size by Country (2019-2024)
7.4 Europe Infertility Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infertility Testing Market Size (2019-2030)
8.2 Asia-Pacific Infertility Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infertility Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Infertility Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infertility Testing Market Size (2019-2030)
9.2 Latin America Infertility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infertility Testing Market Size by Country (2019-2024)
9.4 Latin America Infertility Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infertility Testing Market Size (2019-2030)
10.2 Middle East & Africa Infertility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infertility Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Infertility Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Infertility Testing Introduction
11.1.4 Merck Revenue in Infertility Testing Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Procter & Gamble
11.2.1 Procter & Gamble Company Detail
11.2.2 Procter & Gamble Business Overview
11.2.3 Procter & Gamble Infertility Testing Introduction
11.2.4 Procter & Gamble Revenue in Infertility Testing Business (2019-2024)
11.2.5 Procter & Gamble Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Infertility Testing Introduction
11.3.4 BioMerieux Revenue in Infertility Testing Business (2019-2024)
11.3.5 BioMerieux Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Infertility Testing Introduction
11.4.4 Abbott Revenue in Infertility Testing Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Babystart
11.5.1 Babystart Company Detail
11.5.2 Babystart Business Overview
11.5.3 Babystart Infertility Testing Introduction
11.5.4 Babystart Revenue in Infertility Testing Business (2019-2024)
11.5.5 Babystart Recent Development
11.6 BioZhena Corporation
11.6.1 BioZhena Corporation Company Detail
11.6.2 BioZhena Corporation Business Overview
11.6.3 BioZhena Corporation Infertility Testing Introduction
11.6.4 BioZhena Corporation Revenue in Infertility Testing Business (2019-2024)
11.6.5 BioZhena Corporation Recent Development
11.7 Quidel Corporation
11.7.1 Quidel Corporation Company Detail
11.7.2 Quidel Corporation Business Overview
11.7.3 Quidel Corporation Infertility Testing Introduction
11.7.4 Quidel Corporation Revenue in Infertility Testing Business (2019-2024)
11.7.5 Quidel Corporation Recent Development
11.8 SPD Swiss Precision Diagnostics GmbH
11.8.1 SPD Swiss Precision Diagnostics GmbH Company Detail
11.8.2 SPD Swiss Precision Diagnostics GmbH Business Overview
11.8.3 SPD Swiss Precision Diagnostics GmbH Infertility Testing Introduction
11.8.4 SPD Swiss Precision Diagnostics GmbH Revenue in Infertility Testing Business (2019-2024)
11.8.5 SPD Swiss Precision Diagnostics GmbH Recent Development
11.9 SCSA Diagnostics
11.9.1 SCSA Diagnostics Company Detail
11.9.2 SCSA Diagnostics Business Overview
11.9.3 SCSA Diagnostics Infertility Testing Introduction
11.9.4 SCSA Diagnostics Revenue in Infertility Testing Business (2019-2024)
11.9.5 SCSA Diagnostics Recent Development
11.10 Pride Angel
11.10.1 Pride Angel Company Detail
11.10.2 Pride Angel Business Overview
11.10.3 Pride Angel Infertility Testing Introduction
11.10.4 Pride Angel Revenue in Infertility Testing Business (2019-2024)
11.10.5 Pride Angel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Merck
Procter & Gamble
BioMerieux
Abbott
Babystart
BioZhena Corporation
Quidel Corporation
SPD Swiss Precision Diagnostics GmbH
SCSA Diagnostics
Pride Angel

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂